SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Michael Andreeff Jorge Eduardo Cortes Juliana M Benito Arthur E. Frankel Hagop Kantarjian Marina Konopleva Borys Korchin |
| Publication date | June 19, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |